 |
|
Neuropathologic Features of Amnestic Mild Cognitive Impairment
Ronald C. Petersen, PhD, MD;
Joseph E. Parisi, MD;
Dennis W. Dickson, MD;
Kris A. Johnson, RN;
David S. Knopman, MD;
Bradley F. Boeve, MD;
Gregory A. Jicha, MD, PhD;
Robert J. Ivnik, PhD;
Glenn E. Smith, PhD;
Eric G. Tangalos, MD;
Heiko Braak, MD;
Emre Kokmen, MD
Arch Neurol. 2006;63:665-672.
Background The neuropathologic substrate of amnestic mild cognitive impairment (aMCI) is not known.
Objective To determine the neuropathologic features of patients who died while their clinical classification was aMCI.
Design Cohort study.
Setting Community based.
Participants Sixty-six individuals, including 15 who had memory impairment beyond that allowed for aging but who were not demented, were studied along with 28 clinically healthy individuals and 23 patients with probable Alzheimer disease (AD) for comparison.
Main Outcome Measures Standard neuropathologic techniques and classification according to Khachaturian, Consortium to Establish a Registry for Alzheimer Disease, and National Institute on Aging–Reagan criteria were used to analyze autopsy tissue from 15 individuals who died while their clinical diagnosis was aMCI. For comparison, autopsy data on age-matched groups of clinically healthy individuals and patients with probable AD were analyzed.
Results Most patients with aMCI did not meet the neuropathologic criteria for AD, but their pathologic findings suggest a transitional state of evolving AD. All the patients with aMCI had pathologic findings involving medial temporal lobe structures, likely accounting for their memory impairment. In addition, there were many concomitant pathologic abnormalities, including argyrophilic grain disease, hippocampal sclerosis, and vascular lesions.
Conclusions The neuropathologic features of aMCI matched the clinical features and seemed to be intermediate between the neurofibrillary changes of aging and the pathologic features of very early AD.
Author Affiliations: Alzheimer's Disease Research Center (Drs Petersen, Parisi, Dickson, Knopman, Boeve, Jicha, Ivnik, Smith, Tangalos, and Kokmen and Ms Johnson) and Departments of Neurology (Drs Petersen, Knopman, Boeve, Jicha, and Kokmen), Laboratory Medicine and Pathology (Dr Parisi), Neurosciences (Dr Dickson), Psychiatry and Psychology (Drs Ivnik and Smith), and Internal Medicine (Dr Tangalos), Mayo Clinic College of Medicine, Rochester, Minn, and Jacksonville, Fla; and Institute for Clinical Anatomy, J.W. Goethe University, Frankfurt, Germany (Dr Braak).
Deceased.
RELATED ARTICLE
Neuropathology of Amnestic Mild Cognitive Impairment
Harry V. Vinters
Arch Neurol. 2006;63(5):645-646.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Argyrophilic grain disease
Ferrer et al.
Brain 2008;131:1416-1432.
ABSTRACT
| FULL TEXT
Mild Cognitive Impairment: Challenging Issues
Ganguli and Petersen
AJGP 2008;16:339-342.
FULL TEXT
Processing resources reduce the effect of Alzheimer pathology on other cognitive systems
Boyle et al.
Neurology 2008;70:1534-1542.
ABSTRACT
| FULL TEXT
Change in Depressive Symptoms During the Prodromal Phase of Alzheimer Disease
Wilson et al.
Arch Gen Psychiatry 2008;65:439-445.
ABSTRACT
| FULL TEXT
MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment
Whitwell et al.
Neurology 2008;70:512-520.
ABSTRACT
| FULL TEXT
Clinical Prediction of Alzheimer Disease Dementia Across the Spectrum of Mild Cognitive Impairment
Dickerson et al.
Arch Gen Psychiatry 2007;64:1443-1450.
ABSTRACT
| FULL TEXT
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease
Boeve et al.
Brain 2007;130:2770-2788.
ABSTRACT
| FULL TEXT
{beta}-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
Pike et al.
Brain 2007;130:2837-2844.
ABSTRACT
| FULL TEXT
Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Cummings et al.
Neurology 2007;69:1622-1634.
ABSTRACT
| FULL TEXT
Conscientiousness and the Incidence of Alzheimer Disease and Mild Cognitive Impairment
Wilson et al.
Arch Gen Psychiatry 2007;64:1204-1212.
ABSTRACT
| FULL TEXT
A plateau in pre-Alzheimer memory decline: Evidence for compensatory mechanisms?
Smith et al.
Neurology 2007;69:133-139.
ABSTRACT
| FULL TEXT
Olfactory Identification and Incidence of Mild Cognitive Impairment in Older Age
Wilson et al.
Arch Gen Psychiatry 2007;64:802-808.
ABSTRACT
| FULL TEXT
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease
Whitwell et al.
Brain 2007;130:1777-1786.
ABSTRACT
| FULL TEXT
Chronic distress and incidence of mild cognitive impairment
Wilson et al.
Neurology 2007;68:2085-2092.
ABSTRACT
| FULL TEXT
Transitions to Mild Cognitive Impairments, Dementia, and Death: Findings from the Nun Study
Tyas et al.
Am J Epidemiol 2007;165:1231-1238.
ABSTRACT
| FULL TEXT
Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline
Panza et al.
Neurology 2007;68:964-965.
FULL TEXT
Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis
Forman et al.
Neurology 2007;68:757-763.
ABSTRACT
| FULL TEXT
PET of Brain Amyloid and Tau in Mild Cognitive Impairment
Small et al.
NEJM 2006;355:2652-2663.
ABSTRACT
| FULL TEXT
Pathologic and Nicotinic Receptor Binding Differences Between Mild Cognitive Impairment, Alzheimer Disease, and Normal Aging
Sabbagh et al.
Arch Neurol 2006;63:1771-1776.
ABSTRACT
| FULL TEXT
A Century of Alzheimer's Disease
Goedert and Spillantini
Science 2006;314:777-781.
ABSTRACT
| FULL TEXT
Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease
Singh et al.
Brain 2006;129:2885-2893.
ABSTRACT
| FULL TEXT
Mild Cognitive Impairment Should Be Considered for DSM-V
Petersen and O'Brien
J Geriatr Psychiatry Neurol 2006;19:147-154.
ABSTRACT
Diagnostic Issues in Dementia: Neuroimaging as a Surrogate Marker of Disease
Small
J Geriatr Psychiatry Neurol 2006;19:180-185.
ABSTRACT
Neuropathology of amnestic mild cognitive impairment.
Vinters
Arch Neurol 2006;63:645-646.
FULL TEXT
Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha et al.
Arch Neurol 2006;63:674-681.
ABSTRACT
| FULL TEXT
|
